NCT00336453: Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics |
|
|
| Completed | 1/2 | 156 | US | Influenza Vaccination, FluBlok, Fluzone, rHA, rHA0, recombinant hemagglutinin, TIV | Protein Sciences Corporation | Influenza | 07/07 | 07/07 | | |